Statistics on Biotechnology Use  
Results by sector of operation
Total sectors. Biotechnology results by main variables and fields of operation. 
Units: specified in variables

;Total;Units;P.A.;Higher Education;PNPI;
Units that perform R+D in Biotechnology;1,332;1,133;120;67;12;
%Units according to biotechnology used: Genetic code;41;33;88;87;33;
%Units according to biotechnology used: Functional units;48;41;89;91;50;
%Units according to biotechnology used: Cellular and tissue culturing and engineering;31;24;74;82;50;
%Units according to biotechnology used: Bioprocesses;53;50;61;93;42;
%Units according to biotechnology used: Sub-cellular organisms;14;6;56;72;33;
%Units according to biotechnology used: Bio-computing;31;24;69;85;8;
%Units according to biotechnology used: Nanobiotechnology;19;13;50;70;8;
%Units according to biotechnology used: Other;14;14;8;18;8;
Units in which biotechnology activities are:  Main and/or exclusive;647;603;33;5;6;
Units in which biotechnology activities are: A secondary line of business;252;173;39;38;2;
Units in which biotechnology activities are: A tool necessary for production;433;357;48;24;4;
%Units by field(s) of ultimate application of biotechnology use: Human health;51;45;78;91;58;
%Units by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;20;18;15;67;8;
%Units by field(s) of ultimate application of biotechnology use: Food products;32;31;20;79;8;
%Units by field(s) of ultimate application of biotechnology use: Agriculture and forest production:;24;22;19;73;25;
%Units by field(s) of ultimate application of biotechnology use: Environment;17;14;22;72;17;
%Units by field(s) of ultimate application of biotechnology use: Industry;15;12;12;67;8;
Personnel in R&D in biotechnology (no. of persons);40,018;11,510;13,944;14,415;149;
Personnel in R&D in biotechnology (no. of persons): Researchers;26,603;6,202;8,687;11,634;80;
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;13,415;5,308;5,257;2,781;69;
Personnel in R&D in biotechnology (no. of persons): women;22,240;6,389;8,590;7,165;96;
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;13,936;3,304;5,040;5,545;47;
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;8,305;3,086;3,550;1,620;49;
Personnel in R&D in biotechnology (FTE);27,550.6;8,236.9;10,492.6;8,726.3;94.8;
Personnel in R&D in biotechnology (FTE): Researchers;17,572.9;4,596.1;6,124.4;6,798.1;54.3;
Personnel in R&D in biotechnology (FTE): Technicians and assistants;9,977.7;3,640.8;4,368.2;1,928.2;40.5;
Personnel in R&D in biotechnology (FTE): women;15,792.1;4,698.5;6,519.9;4,509.0;64.7;
Personnel in R&D in biotechnology (FTE): (women) Researchers;9,524.4;2,512.5;3,603.3;3,374.3;34.3;
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;6,267.7;2,186.0;2,916.6;1,134.7;30.4;
Internal expenditure on R&D (thousands of euros);1,783,011;769,431;596,928;411,163;5,489;
1) By nature of the expense: Current expenses;1,673,710;719,715;567,086;381,526;5,383;
1.1) Remuneration to researchers;677,784;221,447;225,782;228,981;1,573;
1.2) Remuneration to technicians and assistants;290,584;122,809;107,902;58,884;989;
1.3) Other current expenses;705,342;375,459;233,402;93,661;2,820;
2) By nature of the expense: Capital expenses;109,301;49,715;29,842;29,637;106;
2.1) Land and buildings;18,585;9,521;3,511;5,553;0;
2.2) Equipment and instruments;78,285;30,466;25,115;22,598;106;
2.3) Acquisition of specific R+D software;4,139;1,810;1,014;1,314;1;
2.4) Otros productos de propiedad intelectual específicos para I+D;8,292;7,919;202;172;0;
1.1) By origin of the funds: Own funds;639,755;490,913;69,873;78,383;585;
1.2) By origin of the funds: From companies;189,495;82,548;77,770;28,349;828;
1.3) By origin of the funds: Public Administration funds;737,076;96,809;379,076;258,952;2,239;
1.4) By origin of the funds: From Universities;2,962;197;1,380;1,309;75;
1.5) By origin of the funds: From non profit private institutions;24,088;4,766;11,426;6,679;1,217;
1.6) By origin of the funds: Foreign funds;189,635;94,197;57,401;37,492;545;
Purchase of services R & D in Biotechnology to (thousands of euros);153,607;120,281;26,850;6,101;375;
Purchase of services R & D in Biotechnology to (thousands of euros): in Spain;98,024;69,564;22,379;5,769;312;
Purchase of services R & D in Biotechnology to (thousands of euros): Abroad;55,583;50,718;4,470;332;63;
%Units that consider the following obstacles as very important considering biotechnology development: Access to capital;47;45;59;58;75;
%Units that consider the following obstacles as very important considering biotechnology development: Access to technology / information;12;12;3;12;25;
%Units that consider the following obstacles as very important considering biotechnology development: Access to human resources;20;16;41;40;33;
%Units that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;16;14;28;36;25;
%Units that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;19;16;33;43;33;
%Units that consider the following obstacles as very important considering biotechnology development: Lack of distribution and marketing channels;20;18;30;40;25;
%Units that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;15;15;11;11;33;
%Units that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;37;37;42;34;42;
%Units that consider the following obstacles as very important considering biotechnology development: Time / cost;53;52;61;61;58;
%Units that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;20;20;20;19;25;
%Units that have requested biotechnology patents in Biotechnology;21;15;45;75;8;
Number of patents requested;1,785;681;555;548;1;
Notes:
1) '..'=data not available 

 '.'=numeric piece of data equal to zero not resulting from rounding 

 FTE: Full Time Equivalent 

 (*) Total calculated from the total number of companies with related activities  with Biotechnology and the total units from other sectors with activities  in R&D in Biotechnology
Source: National Statistics Institute